Sherry Heldens
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- interferon and immune responses
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
-
- Immune Response and Inflammation 2
- T-cell and B-cell Immunology 2
- interferon and immune responses 1
- Phagocytosis and Immune Regulation 1
-
- Melanoma and MAPK Pathways 1
- Co-authors
- Wyne P. Lee (2 shared papers)Vishva M. Dixit (2 shared papers)Kim Newton (1 shared paper)Yan Qu (1 shared paper)Søren Warming (1 shared paper)Merone Roose‐Girma (1 shared paper)Nobuhiko Kayagaki (1 shared paper)Lieselotte Vande Walle (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)The Journal of Immunology (1 paper)Nature (1 paper)Current Biology (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Sherry Heldens
6 papers receiving 3.8k citations
Sherry Heldens's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 1.3k
- Oncology 1.0k
- Nephrology 261
- Molecular Biology 2.4k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Sherry Heldens
This map shows the geographic impact of Sherry Heldens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Heldens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Heldens more than expected).
Fields of papers citing papers by Sherry Heldens
This network shows the impact of papers produced by Sherry Heldens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Heldens. The network helps show where Sherry Heldens may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherry Heldens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-canonical inflammasome activation targets caspase-11 Hit paper breakdown → | 2011 | 2015 |
| 2 | Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib Hit paper breakdown → | 2005 | 1200 |
| 3 | 2000 | 284 | |
| 4 | 2012 | 155 | |
| 5 | 1999 | 152 | |
| 6 | 2010 | 14 |
About Sherry Heldens
Sherry Heldens is a scholar working on Immunology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 6 papers that have together received 3.8k indexed citations. Recurring topics across this work include Immune Response and Inflammation (2 papers), T-cell and B-cell Immunology (2 papers), interferon and immune responses (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Phagocytosis and Immune Regulation (1 paper), Melanoma and MAPK Pathways (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.0k citations), Nephrology (261 citations), Molecular Biology (2.4k citations) and Pulmonary and Respiratory Medicine (1.0k citations). Sherry Heldens has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Wyne P. Lee, Vishva M. Dixit, Kim Newton, Yan Qu, Søren Warming, Merone Roose‐Girma, Nobuhiko Kayagaki, Lieselotte Vande Walle, Juan Zhang and Jennifer J. Dong. Their work appears in journals such as Molecular Cancer Therapeutics, The Journal of Immunology, Nature, Current Biology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.